Stocktoria
Autolus Therapeutics plc AUTL
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-06-22
Chart by TradingView
2/9
Piotroski F — financial health
-6.27
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $75.4M | $10.1M | $1.7M | — | — |
| Operating income | -$270.5M | -$241.4M | -$179.7M | -$143.4M | -$141.1M |
| Net income | -$287.5M | -$220.7M | -$208.4M | -$148.8M | -$142.1M |
| Operating cash flow | -$283.6M | -$206.3M | -$145.6M | -$112.3M | -$117.9M |
| Free cash flow | -$302.6M | -$228.3M | -$156.6M | -$123.1M | -$126.7M |
| Total assets | $589.1M | $782.7M | $375.4M | $490.3M | $405.6M |
| Total liabilities | $410.9M | $355.4M | $263.9M | $191.6M | $92.2M |
| Shareholders' equity | $178.1M | $427.3M | $111.5M | $298.7M | $313.3M |
| Ratios | |||||
| Operating margin | -358.9% | -2385.6% | -10583.1% | — | — |
| Net margin | -381.4% | -2180.5% | -12272.3% | — | — |
| FCF margin | -401.4% | -2256.4% | -9221.0% | — | — |
| Return on assets | -48.8% | -28.2% | -55.5% | -30.4% | -35.0% |
| Return on equity | -161.4% | -51.6% | -186.9% | -49.8% | -45.4% |
| Current ratio | 5.94 | 10.88 | 6.15 | 9.18 | 12.15 |
| Revenue growth | 644.9% | 496.0% | — | — | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 2,299,499 | $3.2M |
| Point72 Asset Management, L.P. | 426,983 | $589,237 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -6.27 (distress)
- Working capital / assets 0.615
- Retained earnings / assets -2.354
- EBIT / assets -0.459
- Equity / liabilities 0.433
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001730463 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.